For Merck, Asthma Drug Helps Offset Earnings Fall

Tuesday, July 21, 2009 - 23:35 in Health & Medicine

The company’s acquisition of Schering-Plough later this year could help Merck’s bottom line.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net